DGMT - Tao Chen E07796 possible CDER funding Sequencing contract

The Food and Drug Administration is forecasting a potential sequencing contract under the NAICS code 541714, targeting research and development in the biological sciences, specifically involving Tao Chen with identifier E07796 and possible funding from the Center for Drug Evaluation and Research. The opportunity was posted on May 25, 2026, and remains in a forecast stage with no solicitation number assigned or set-aside designation specified. Performance location and detailed office address information are not yet defined, indicating the scope and logistics are still under development. The program point of contact is the NCTR Acquisition Liaison, reachable via nctracquisitions@fda.hhs.gov, while the contracting officer position remains unfilled with contact details listed as to be determined, signaling that formal procurement activities have not commenced. Interested parties should monitor the OSDBU opportunity forecast link for updates as the procurement progresses toward a formal solicitation.